Catalyst Wire Dossier Catalyst Wire Dossier

Fispemifene

· QuatRx Pharmaceuticals Company
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Fispemifene, covering 2008-03-03 to 2015-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men [Phase 2]

See pricing